Growth Metrics

MeiraGTx Holdings (MGTX) Cash & Equivalents (2017 - 2025)

MeiraGTx Holdings posted quarterly Cash & Equivalents of $65.9 million for Q4 2025, down 36.4% year-on-year from $103.7 million in Q4 2024, and up 344.25% on a QoQ basis from $14.8 million in Q3 2025.

MeiraGTx Holdings (MGTX) has 9 years of Cash & Equivalents data on file, last reported at $65.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents fell 36.4% year-over-year to $65.9 million; the trailing twelve-month figure through Dec 2025 stood at $65.9 million (down 36.4% YoY), and the FY2025 full-year result was $65.9 million, down 36.4% from the prior year.
  • Cash & Equivalents for Q4 2025 stood at $65.9 million, up from $14.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $199.4 million in Q1 2021 and bottomed at $14.8 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $108.7 million (2022), against an average of $102.8 million.
  • The widest annual swing landed in 2024, when Cash & Equivalents surged 94.14%; it then sank 88.13% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $137.7 million in 2021, then decreased by 16.11% to $115.5 million in 2022, then rose by 13.1% to $130.6 million in 2023, then dropped by 20.66% to $103.7 million in 2024, then tumbled by 36.4% to $65.9 million in 2025.
  • The last three Cash & Equivalents figures came in at $65.9 million (Q4 2025), $14.8 million (Q3 2025), and $32.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 1.91 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 32.30 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 61.46 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.71 Bn
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn 65.93 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 65.93 Mn
Sep 30, 2025 14.84 Mn
Jun 30, 2025 32.17 Mn
Mar 31, 2025 66.52 Mn
Dec 31, 2024 103.66 Mn
Sep 30, 2024 125.03 Mn
Jun 30, 2024 101.03 Mn
Mar 31, 2024 120.27 Mn
Dec 31, 2023 130.65 Mn
Sep 30, 2023 64.40 Mn
Jun 30, 2023 92.77 Mn
Mar 31, 2023 68.78 Mn
Dec 31, 2022 115.52 Mn
Sep 30, 2022 114.71 Mn
Jun 30, 2022 72.11 Mn
Mar 31, 2022 113.78 Mn
Dec 31, 2021 137.70 Mn
Sep 30, 2021 143.63 Mn
Jun 30, 2021 172.56 Mn
Mar 31, 2021 199.41 Mn
Dec 31, 2020 209.52 Mn
Sep 30, 2020 179.33 Mn
Jun 30, 2020 194.81 Mn
Mar 31, 2020 210.41 Mn
Dec 31, 2019 227.23 Mn
Sep 30, 2019 253.45 Mn
Jun 30, 2019 204.40 Mn
Mar 31, 2019 227.40 Mn
Dec 31, 2018 68.20 Mn
Sep 30, 2018 88.68 Mn
Jun 30, 2018 102.18 Mn
Mar 31, 2018 32.48 Mn
Dec 31, 2017 8.67 Mn
Sep 30, 2017 5.42 Mn
Jun 30, 2017 5.33 Mn